INCY
INCY
NASDAQ · Biotechnology

Incyte Corp

S&P 500 Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks
$120.56
+2.18 (+1.84%)
As of Aug 8, 1:09 AM ET ·
Analyst Consensus
Hold
33
Analysts
Very High
Coverage
Buy 17 52%
Hold 16 48%
Sell 0 0%
Price Target
Analyst Price Target +71.5% upside
Low Target $125.25
Average Target $206.81
High Target $260.19
Current Price $120.56
Current
$120.56
Target
$206.81
$125.25 $206.81 avg $260.19
Scenario Analysis
Bear Case
$125.25
3.9%
Low target
Base Case
$206.81
+71.5%
Avg target
Bull Case
$260.19
+115.8%
High target
Risk/Reward
29.8x
Highly favorable
Price in Context
52-Week High
$132.60
-9.1% from high
52-Week Low
$76.45
+57.7% from low
50-Day SMA
$101.74
+18.5% vs SMA
200-Day SMA
$86.15
+39.9% vs SMA
RSI (14)
51.1
Neutral
Target vs 52W High
$206.81
+56.0% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 39 79% $257.58 +4.7%
AMGN
Amgen Inc
 Hold 43 49% $190.87 -53.6%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +172.3%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -11.6%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -90.2%
NTRA
Natera Inc
 Strong Buy 30 87% $142.91 -55.6%
RVMD
Revolution Medicines Inc
 Strong Buy 29 93% $114.11 -44.4%
BIIB
Biogen Inc
 Buy 44 64% $91.45 -56.0%